David Dodds

Process development at the interface of chemistry and biology. IT adventurer.

How does this work?
Work experience

Apr 2020 - Present

Galy, Co.

Interim Chief Technology Officer

Jan 2019 - Present


Co-founder and Chief Data Scientist

Keydabra uses advanced proprietary machine/deep learning algorithms to automate and improve digital, social and mobile apps user engagement and optimize online conversions. Visit us at www.keydabra.com

Oct 2016 - Present


Expert at Lee Enterprises Consulting

Lee Enterprises Consulting is the world’s premier bioeconomy consulting group with over 100 bioenergy and biochemical experts worldwide. Our experts are world renowned leaders in their field, selected based on their education, experience, and reputation and have done thousands of projects worldwide. Lee Enterprises Consulting is divided into five sections – biofuels, biomaterials& biochemicals, feedstocks, technologies, and cannabis/hemp. Our services encompass business & financial, technical & engineering, project management, legal & regulatory, and a variety of specialty services like litigation support (expert witness), TEA, executive recruiting, risk analysis, insurance, accounting, and more. Our size makes us the largest bioeconomy consulting group in the world.

Jan 2005 - Present

Rondaxe Pharma

Sr. Advisor

Technical advice to clients for fermentation scale-up, total synthesis, biocatalysis, protein purification; all under GMP

Jan 2002 - Present

Dodds & Associates LLC


Advising start-ups in pharma, renewable/bio-based chemicals & industrial biotech since 2002. David Dodds has over 30 years experience leading interdisciplinary process development groups using biocatalysis and other biological methods to perform organic synthesis. As Dodds & Associates, he provides executive level technical strategy, project management, and due diligence across multiple disciplines at the interface of chemistry and biology . David also provides expert witness service for patent litigation, and service on SABs. Competencies: organic synthesis, chiral chemistry, biocatalysis, molecular biology, industrial biotech, natural product fermentation, chemical process development


Jul 1999 - Oct 2001

Bristol-Myers Squibb Co.

Director; Fermentation & Biocatalysis Development

Invited to BMS to lead a new group of 50 scientists covering chemical process development, molecular biology, fermentation development, and GMP analytical functions. Achieved cost-savings by applying biocatalysis in chemical syntheses. Developed chiral chemical processes, plus fermentations for natural products, enzymes, and biocatalysis.


Aug 1991 - Jun 1999

Schering-Plough Research Institute

Manager, Biotransformation

Invited to SPRI to establish a new group for the development of biocatalysis for more efficient and cost-effective syntheses of pharmaceuticals. Reported to VPs of both Chemical and Biotechnology Development. Responsible for budget (operational and capital), staffing and equipping, physical plant requirements, and all regulatory compliance (environmental, S&IH, GMP) for the Group.

May 1986 - Jul 1991

Sepracor, Inc.

Sr. Scientist

Responsible for biocatalysis research to create commercial opportunities for Sepracor's core membrane bioreactor technology. Included design and chemical synthesis of substrates, design and implementation of enzyme/substrate screening assays, and technical support for engineering.

Talk to David

@ Copyright 2020 OfficeHours Technologies Co.